Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates

Clinical & Translational Immunology(2022)10.1002/cti2.1379Source: DataRank Database

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates is a research paper published in Clinical & Translational Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.48)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Sandra Muschiol,Nastasiya F. Grinberg ORCID,Soo Aleman ORCID,Daniel J. Sheward ORCID,Leo Hanke ORCID

Live enrichment

PubMed:35284072 PMC:PMC8891432 OpenAlex:https://openalex.org/W4214811183

Vetenskapsrådet

Grant: 2017‐00968

Vetenskapsrådet

Grant: 2020‐06235

National Institutes of Health

Grant: 400 SUM1A44462‐02

European Commission

Grant: 101003653

Nanobodies and antibodies against 2019-nCoV

Wellcome Trust

Grant: 107881

Partitioning autoimmune diseases on their molecular basis.

Wellcome Trust

Grant: 220788

Medical Research Council

Grant: MC_UP_1302/5

Wellcome Trust

Grant: 107881/Z/15/Z

Medical Research Council

Grant: MC_UU_00002/4

Swedish Research Council

Grant: unidentified

unidentified

FWCI

0.48

Citation Percentile

0.6%

Citation Trend

2020

2022

2023

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cti2.1379

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cti2.1379

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1379

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cti2.1379

journalhttps://doi.org/10.1002/cti2.1379

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciences

Keywords

SerostatusCutoffLinear discriminant analysisSeroprevalencePopulationMedicineStatisticsEpidemiologySerologyImmunologyAntibodyInternal medicineMathematicsHuman immunodeficiency virus (HIV)Probabilityantibody responsesAntibody testingCovid‐19Sars‐cov‐2Infectious MedicineSARS-CoV-2COVID-19Immunology in the medical areaInfektionsmedicinRC581-607Immunologi inom det medicinska områdetOriginal ArticleImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Reduced inequalities